Fig. 5From: Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositisPlasma concentration of SPP1 in relation to disease subtypes. A The cartoon shows the three subgroups in MDA5+ DM patients with mild (cluster 1), moderate (cluster 2), and high RP-ILD risk (cluster 3) that were identified by our previous study. B Plasma concentration of SPP1 in different MDA5+ DM subtypesBack to article page